Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Jan 15, 2024; 15(1): 11-14
Published online Jan 15, 2024. doi: 10.4239/wjd.v15.i1.11
Individualized intensive insulin therapy of diabetes: Not only the goal, but also the time
Yun Hu, Hong-Jing Chen, Jian-Hua Ma
Yun Hu, Hong-Jing Chen, Department of Endocrinology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi 214023, Jiangsu Province, China
Jian-Hua Ma, Department of Endocrinology, Nanjing First Hospital, Nanjing 210000, Jiangsu Province, China
Author contributions: Hu Y and Chen HJ drafted the initial manuscript; Ma JH conceptualized and revised the manuscript.
Conflict-of-interest statement: All the Authors have no conflict of interest related to the manuscript.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jian-Hua Ma, MD, Professor, Department of Endocrinology, Nanjing First Hospital, No. 32 Gongqingtuan Road, Nanjing 210000, Jiangsu Province, China. majianhua@china.com
Received: October 27, 2023
Peer-review started: October 27, 2023
First decision: November 23, 2023
Revised: December 3, 2023
Accepted: December 25, 2023
Article in press: December 25, 2023
Published online: January 15, 2024
Core Tip

Core Tip: Intensive insulin therapy is popular in the treatment of patients with diabetes. This article highlighted the effects and side effects of intensive insulin therapy. It is a warning against the use of insulin therapy without any limitations, such as the speed of blood glucose lowering and the duration of insulin therapy.